H.R. 608 — Pharmaceutical Products Price Equity Act

Summary

Pharmaceutical Products Price Equity Act - Directs the President to issue orders and regulations, and establish procedures and reporting requirements, to ensure that no pharmaceutical product is sold to any consumer in the United States at a price that is more than six percent above the average retail price at which such pharmaceutical product is sold in the five most industrialized, free-market countries, other than the United States. Sets forth enforcement and civil liability provisions.

Full Text

Legislative Actions

2003-02-05
Introduced in House
2003-02-05
Introduced in House
2003-02-05
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2003-02-05
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2003-02-05
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2003-02-14
Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
2003-03-06
Referred to the Subcommittee on Courts, the Internet, and Intellectual Property.

Pharmaceutical Products Price Equity Act

Sponsors

Subjects

Summary

Full Text

Legislative Actions

Ask about this bill